UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-K/A
Amendment No. 1
xANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014
Or
oTRANSITION REPORT PURSUANT TO SECTION 13 OF 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
COMMISSION FILE NUMBER 333-136436
MEDICAL IMAGING CORP.
(Exact name of registrant as specified in charter)
NEVADA |
| 98-0493698 |
(State or other jurisdiction of incorporation or organization) |
| (I.R.S. Employer Identification No.) |
848 N. Rainbow Blvd. #2494, Las Vegas, Nevada |
| 89107 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant's telephone number, including area code: (877)-331-3444
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act: Common Stock, $.001 par value
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 of 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer o | Accelerated filer o |
Non-accelerated filer o (Do not check if smaller reporting company) | Smaller reporting company x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.). Yes o No x
Aggregate market value of the 12,119,981 outstanding shares of common stock held by non-affiliates of the Registrant as of June 30, 2014 was approximately $956,267, based on the closing sales price of the registrant’s common stock on that date.
There were 24,166,481 shares of common stock outstanding as of March 15, 2015.
Explanatory Paragraph:
On April 3, 2015, Medical Imaging Corp. filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2014 (the “Form 10-K”). Attached as Exhibit 10.2 to the Form 10-K was a Royalty Agreement, dated October 31, 2014. The Royalty Agreement was filed pursuant to a confidential treatment request (the “CTR”). Among the items subject to the CTR was the percentage of the Gross Sales Royalty (as such term is defined in Section 2.2 of the Royalty Agreement) used in calculating the monthly royalty payment. The copy of the Royalty Agreement as filed with the SEC inadvertently disclosed the Gross Sales Royalty percentage to be 1%. That number is not correct. The actual percentage is not 1%, but another number other than 1%. The purpose of this Amendment to re-file the Royalty Agreement with the Gross Sales Royalty percentage redacted.
2
PART IV
ITEM 15. EXHIBITS
________________________________________________
1. Incorporated by reference from the Registrant’s Registration Statement on Form SB-2 filed with the SEC on
August 9, 2006.
2. Incorporated by reference from the Registrant’s Current Report on Form 8-K filed with the SEC on July 11, 2014.
3. Incorporated by reference from the Registrant’s Current Report on Form 8-K filed with the SEC on March 5, 2009.
3. Incorporated by reference from the Registrant’s Current Report on Form 8-K filed with the SEC on December 6, 2010.
5. Incorporated by reference from the Registrant’s Current Report on Form 8-K filed with the SEC on August 13, 2012.
6. Incorporated by reference from the Registrant’s Current Report on Form 8-K filed with the SEC on December 5, 2012.
7. Incorporated by reference from the Registrant’s Current Report on Form 8-K filed with the SEC on December 5, 2012.
8. Incorporated by reference from the Registrant’s Current Report on Form 8-K filed with the SEC on May 22, 2014.
9. Incorporated by reference from the Registrant’s Current Report on Form 8-K filed with the SEC on May 22, 2014.
10. Incorporated by reference from the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2014 filed with the SEC on April 3, 2015.
* Filed herewith.
3
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MEDICAL IMAGING CORP. | |
|
|
|
|
|
|
| By: | /s/ Mitchell Geisler |
|
| Mitchell Geisler |
|
| Chief Executive Officer |
|
|
|
| Date: | May 26, 2015 |
Pursuant to the requirements with the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
4
